- Question from GinaS: How much do we know about triple-negative breast cancer? Why does it hit African American women so hard? Thank you.
- Answers - Generosa Grana, M.D., F.A.C.P We don't know very much about triple-negative disease, but there is a lot of research specifically focused on this area. We know it tends to be more aggressive in its behavior, but we don't yet have any specific target, such as the estrogen receptor or the HER2/neu receptor that can be used to alter its behavior. Why we see such a significant amount of triple-negative disease in young African American women is not at all understood. For a more in-depth discussion of this topic, please take part in the upcoming Breastcancer.org teleconference entitled Triple-Negative Breast Cancer, with Dr. George Sledge from Indiana University on July 16.
The Ask-the-Expert Online Conference called Updates From the 2008 ASCO Annual Meeting featured Generosa Grana, M.D., F.A.C.P. and Carol Kaplan, M.D. answering your questions about the latest research advances on screening, treatment, side effects, and more.
Editor's Note: This conference took place in June 2008.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.